These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 12171541)

  • 1. Chemotherapeutic potential of curcumin for colorectal cancer.
    Chauhan DP
    Curr Pharm Des; 2002; 8(19):1695-706. PubMed ID: 12171541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells.
    Goel A; Boland CR; Chauhan DP
    Cancer Lett; 2001 Oct; 172(2):111-8. PubMed ID: 11566484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of low COX-2 expression in colorectal neoplasms with defective DNA mismatch repair.
    Karnes WE
    J Cell Biochem Suppl; 2000; 34():23-7. PubMed ID: 10762011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex.
    Plummer SM; Holloway KA; Manson MM; Munks RJ; Kaptein A; Farrow S; Howells L
    Oncogene; 1999 Oct; 18(44):6013-20. PubMed ID: 10557090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.
    Lal G; Ash C; Hay K; Redston M; Kwong E; Hancock B; Mak T; Kargman S; Evans JF; Gallinger S
    Cancer Res; 2001 Aug; 61(16):6131-6. PubMed ID: 11507063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
    Crew TE; Elder DJ; Paraskeva C
    Carcinogenesis; 2000 Jan; 21(1):69-77. PubMed ID: 10607736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibition in colorectal cancer: boom or bust?
    Sanborn R; Blanke CD
    Semin Oncol; 2005 Feb; 32(1):69-75. PubMed ID: 15726508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 in large bowel cancer: a one-sided story.
    DuBOIS RN
    Gut; 1999 Nov; 45(5):636-7. PubMed ID: 10517891
    [No Abstract]   [Full Text] [Related]  

  • 11. A role for cyclooxygenase-2 inhibitors in the prevention and treatment of cancer.
    Howe LR; Dannenberg AJ
    Semin Oncol; 2002 Jun; 29(3 Suppl 11):111-9. PubMed ID: 12138405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.
    Gupta RA; Dubois RN
    Nat Rev Cancer; 2001 Oct; 1(1):11-21. PubMed ID: 11900248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cyclooxygenase-2 in the angiogenesis of colorectal cancer.
    Rao M; Yang W; Seifalian AM; Winslet MC
    Int J Colorectal Dis; 2004 Jan; 19(1):1-11. PubMed ID: 12783255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclooxygenase 2 inhibitors and colorectal cancer].
    Bernardeau-Mozer M; Chaussade S
    Bull Cancer; 2004 May; 91 Spec No():S89-98. PubMed ID: 15239336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib with chemotherapy in colorectal cancer.
    Blanke CD
    Oncology (Williston Park); 2002 Apr; 16(4 Suppl 3):17-21. PubMed ID: 12014863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cyclooxygenase 2 inhibitors and colorectal cancer].
    Bernardeau-Mozer M; Chaussade S
    Bull Cancer; 2004 May; 91 Suppl 2():S89-98. PubMed ID: 15899632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.
    Garcea G; Berry DP; Jones DJ; Singh R; Dennison AR; Farmer PB; Sharma RA; Steward WP; Gescher AJ
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):120-5. PubMed ID: 15668484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical development of leukocyte cyclooxygenase 2 activity as a systemic biomarker for cancer chemopreventive agents.
    Plummer SM; Hill KA; Festing MF; Steward WP; Gescher AJ; Sharma RA
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1295-9. PubMed ID: 11751448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cyclooxygenase(COX)-2-inhibition in the prevention and treatment of colorectal carcinoma].
    Tuynman JB; Hulscher JB; Steller EP; van Lanschot JJ; Richel DJ
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2207-12. PubMed ID: 14640057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective inhibitors of cyclooxygenase-2. Potential in elderly patients.
    Davies NM; Wallace JL
    Drugs Aging; 1996 Dec; 9(6):406-17. PubMed ID: 8972241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.